Will AMC and GameStop Investigate Naked Short Selling?
As the financial markets continue to grapple with the complexities of stock manipulation, a new narrative is emerging on Wall Street.
Investors are increasingly turning their attention to AMC Entertainment Holdings ($AMC) and GameStop Corp. ($GME), two companies that have long been at the center of retail investor fervor.
This shift comes on the heels of bold legal actions by Genius Group ($GNS) and Quantum BioPharma ($QNTM), which have announced lawsuits targeting this controversial practice, sparking a wave of optimism and debate among retail investors on platforms like X.
Further bolstering this movement, Quantum BioPharma recently appointed Kevin Malone, a prominent advocate against stock manipulation, as a board advisor.
A press release dated April 22, 2025, from GlobeNewswire states, “Mr. Malone brings over 40 years of experience in executive leadership and a proven track record of fighting against market manipulation and naked short selling”.
This appointment underscores the company’s commitment to protecting shareholders, a sentiment echoed by Genius Group’s ongoing legal efforts, including a separate RICO lawsuit seeking $450 million in damages for related market manipulation.
AMC and GameStop: The Next Frontier?
The spotlight on $AMC and $GME has intensified as investors question why these high-profile stocks, which experienced dramatic short squeezes in 2021, have not yet followed suit with similar legal actions.
On X, users expressed frustration and hope, with @jason64944736 posting, “@ryancohen bro where you at?”, urging GameStop’s CEO Ryan Cohen to take action.
Similarly, @emily070i lamented, “Does anyone think AMC Board will ever follow this? Nah”, reflecting a mix of skepticism and demand for leadership.
The sentiment on X suggests that investors see $AMC and $GME as natural candidates to lead this charge, given their historical battles with short sellers.
The 2021 GameStop short squeeze saw the stock rise from under $20 to over $483, driven by retail investors — AMC hit over $72 at the time from around $5-$9 per share.
However, the lack of legal action against naked short selling has left some investors disillusioned, with @GameStopNate cautioning, “They did this last year nothing happened… it’s a rinse and repeat”.
Despite this, optimism persists.
@icelandic_pilot posed a critical question: “Finally, some companies are taking a stand against naked shorting about time!
Do you think this will spark real change across the market or just a temporary pop?”.
This reflects a growing belief that $GNS and $QNTM’s actions could pressure $AMC and $GME to act, potentially reshaping market dynamics.
Also Read: Robinhood Now Becomes Center of Allegations in Illegal Short Selling
Why This Matters
GNS and QNTM’s recent surges have fueled speculation that $AMC and $GME could see similar rallies if their boards take decisive action.
GNS stock closed up nearly 23% on Friday while QNTM closed up nearly 16%.
@kjg246’s impassioned plea, “Let’s fucking put all scumbags naked short sellers behind bars… I’ll buy a truckload of mayo, MF will need them behind bars” captures the retail investor anger (and passion) driving this movement.
Analysts suggest that if $AMC and $GME join the fray, the combined market pressure could force regulatory scrutiny.
Quantum BioPharma’s strategic appointment of Malone and Genius Group’s multi-pronged legal approach signal a new era of shareholder activism.
However, the success of this crusade hinges on sustained effort, as past attempts have yielded mixed results.
Whether this marks a turning point in market fairness or another fleeting surge remains to be seen, but the battle lines are clearly drawn.
Back to Daily Market News.
Follow Frank Nez on X or Facebook for more community insights.
Announcement: PR Newswire formally announces Frank Nez’s Journalist Verification on Muck Rack, solidifying our position in independent media.
News You Might Like
